Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




World Cardiovascular Monitoring Market

By HospiMedica staff writers
Posted on 23 Mar 2004
The growing volume of electrocardiogram (ECG) monitoring around the globe has created a strong need among end-users to demand equipment that facilitates effective and reliable management of patient data, according to a new report from Frost & Sullivan (London, UK), an international market analysis firm. More...
The report covers resting ECG, ECG data management, stress testing, Holter, and event monitoring systems, and analyzes key market drivers, restraints, challenges, and strategies.

ECG monitoring equipment with enhanced communication capabilities has been a primary driver of revenue growth in the ECG monitoring equipment market. Increasingly, systems are being networked across various hospital information systems to allow fast and reliable access to complete patient information. Further promoting this trend was the decision by the U.S. Food and Drug Administration (FDA) in 2002 to require all ECG data submitted in support of drug applications to be in digital format.

Many equipment manufacturers are focusing on improving system accuracy, reducing errors, and providing additional clinical capabilities to enhance workflow. This trend is forecast to increase revenues in the resting ECG and ECG data-management segments.
The emergence of personal computer (PC)-based ECG monitoring systems is expected to drive growth within the physicians' office market for resting ECG products by offering cost-effective solutions as well as scalability.

"PC-based ECG monitoring systems allow software components to be added to a core PC system that is part of the diagnostic instrument,” said Seemeen Mirza, an analyst with Frost & Sullivan. "This enables end-users to download relevant software applications and run them on a Windows desktop or notebook computer.” Easy software upgrades to existing hardware platforms help reduce the need for major system upgrades.

The increasing volume of diagnostic cardiovascular monitoring in clinics and offices presents new growth opportunities for manufacturers, as fewer patients are being referred to hospitals for ECG monitoring. Hospitals need to communicate the ways their products and technologies enhance productivity and overall cost savings.

"If manufacturers can tap into the growing need for improved productivity and cost efficiencies in hospitals, they will be the ultimate winners in a large and very integral industry,” added Mirza.




Related Links:
Frost and Sullivan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.